Advertisement

Search Results

Advertisement



Your search for Vamsidhar Velcheti, MD, FACP, FCCP,Vamsidhar Velcheti, MD, FACP, FCCP matches 3 pages

Showing 1 - 3


lung cancer
immunotherapy

New AI-Based Biomarker May Help Predict Immunotherapy Response for Patients With NSCLC

Researchers have discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging scans to help predict which patients with non–small cell lung cancer (NSCLC) will respond to immunotherapy, according to a novel study published by Alilou et al in Science Advances. The...

lung cancer

Highlights From the IASLC 2022 World Conference on Lung Cancer

Over the past few years, we have seen rapid and dramatic transformation in the therapeutic landscape of non–small cell lung cancer (NSCLC). We have had multiple new targeted therapies for newer targets (previously undruggable targets) and better diagnostic strategies to workup patients to realize...

ASCO Welcomes 2019–2020 Leadership Development Program Participants, Education Scholars

ASCO is pleased to announce the 2019–2020 participants in its Leadership Development Program and Education Scholars Program. Leadership Development Program The ASCO Leadership Development Program, which began in 2009, is a year-long program designed to train future leaders in oncology by supporting ...

Advertisement

Advertisement




Advertisement